Cargando…

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

Objective. To compare the efficacy and safety of mycophenolate mofetil (MMF) and intravenous cyclophosphamide (IVC) as induction treatment for lupus nephritis (LN), by race, ethnicity and geographical region. Methods. A total of 370 patients with active Class III–V LN received MMF (target dose 3.0 g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isenberg, David, Appel, Gerald B., Contreras, Gabriel, Dooley, Mary A., Ginzler, Ellen M., Jayne, David, Sánchez-Guerrero, Jorge, Wofsy, David, Yu, Xueqing, Solomons, Neil
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789586/ https://www.ncbi.nlm.nih.gov/pubmed/19933596 http://dx.doi.org/10.1093/rheumatology/kep346

Ejemplares similares

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial
por: McDonald, Stephen, et al.
Publicado: (2022)

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
por: Dall'Era, Maria, et al.
Publicado: (2015)

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis
por: Smilek, Dawn Elaine, et al.
Publicado: (2017)

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
por: Almaani, Salem, et al.
Publicado: (2020)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Time to lupus nephritis: impact of gender and ethnicity
por: Seligman, VA, et al.
Publicado: (2001)

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
por: Ginzler, Ellen M, et al.
Publicado: (2012)

Limited Reliability of the Spot Urine Protein/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis
por: Shidham, Ganesh, et al.
Publicado: (2018)

Very delayed lupus nephritis: a report of three cases and literature review
por: Alexandre, André R, et al.
Publicado: (2018)

Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities
por: Neves, Ana, et al.
Publicado: (2023)

Not Alms, but a Friend
Publicado: (1887)

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
por: Luo, Weike, et al.
Publicado: (2022)

Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis
por: Ntatsaki, Eleana, et al.
Publicado: (2018)

Centriolar Association of ALMS1 and Likely Centrosomal Functions of the ALMS Motif–containing Proteins C10orf90 and KIAA1731
por: Knorz, Victoria J., et al.
Publicado: (2010)

Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia
por: Wen, Qiong, et al.
Publicado: (2022)

Baltimore Alms-House Infirmary
Publicado: (1830)

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
por: Isenberg, David, et al.
Publicado: (2015)

Pediatric lupus nephritis: impact of ethnicity on histological subtype and initial presentation
por: Jurencak, R, et al.
Publicado: (2008)

A farewell to alms : a brief economic history of the world /
por: Clark, Gregory, 1957-
Publicado: (2007)

Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials
por: Corapi, Kristin M, et al.
Publicado: (2015)

Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients
por: Lanata, Cristina M., et al.
Publicado: (2018)

Plasma exchange for concurrent lupus nephritis and antiphospholipid syndrome
por: Sendzischew, Morgan A., et al.
Publicado: (2014)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

The immune cell landscape in kidneys of patients with lupus nephritis
por: Arazi, Arnon, et al.
Publicado: (2019)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

Alme de mi alma : el México de los extranjeros
por: Miller, Carol
Publicado: (2011)

Continuous delivery with Visual Studio ALM 2015
por: Olausson , Mathias, et al.
Publicado: (2015)

Agile ALM: lightweight tools and agile strategies
por: Hüttermann, Michael
Publicado: (2012)

Dialogue: commentary on ‘Engaging African-ancestry participants in systemic lupus erythematosus clinic trials’
por: Ginzler, Ellen M
Publicado: (2018)

Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis
por: Bos, Elisabeth M.J., et al.
Publicado: (2022)

TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009)

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis
por: Gomez Mendez, Liliana Michelle, et al.
Publicado: (2019)

Autoantibodies against C1q as a Diagnostic Measure of Lupus Nephritis: Systematic Review and Meta-analysis
por: Eggleton, Paul, et al.
Publicado: (2014)

Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin
por: Manson, Jessica J, et al.
Publicado: (2014)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73nla5tm7pqu0lm820f0sgcleg